Overview
Felix Effah practices practicing medicine in London, United Kingdom.
His clinical expertise encompasses Cannabinoid Hyperemesis Syndrome (CHS).
He is actively involved in clinical research, co-authoring 17 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Felix Effah
Is Felix Effah a top-rated expert for Cannabinoid Hyperemesis Syndrome (CHS)?
MediFind is an objective health platform that identifies experts based on real-world data. Felix Effah is classified as an Experienced expert for Cannabinoid Hyperemesis Syndrome (CHS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Felix Effah participate in research or clinical trials?
Yes. Felix Effah has published 17 articles and abstracts on conditions like Cannabinoid Hyperemesis Syndrome (CHS). You can view a list of Felix Effah's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Cannabinoid Hyperemesis Syndrome (CHS)